نتایج جستجو برای: artesunate

تعداد نتایج: 1720  

Journal: :Bulletin of the World Health Organization 1999
C Wongsrichanalai T Wimonwattrawatee P Sookto A Laoboonchai D G Heppner D E Kyle W H Wernsdorfer

Reported are the in vitro susceptibilities of Plasmodium falciparum to artesunate, mefloquine, quinine and chloroquine of 86 isolates and to dihydroartemisinin of 45 isolates collected from areas of high resistance to mefloquine within Thailand near the borders with Myanmar and Cambodia, and from southern Thailand where P. falciparum is generally still sensitive to mefloquine. All the isolates ...

Journal: :The Lancet 2005
Arjen Dondorp François Nosten Kasia Stepniewska Nick Day Nick White

BACKGROUND In the treatment of severe malaria, intravenous artesunate is more rapidly acting than intravenous quinine in terms of parasite clearance, is safer, and is simpler to administer, but whether it can reduce mortality is uncertain. METHODS We did an open-label randomised controlled trial in patients admitted to hospital with severe falciparum malaria in Bangladesh, India, Indonesia, a...

2014
Magdalena M. Paczkowski Keren L. Landman Paul M. Arguin

Parenteral artesunate, a first-line treatment for severe malaria in several countries, is associated with increased survival and has a better safety profile compared with parenteral quinine or quinidine. However, parenteral artesunate has been associated with delayed hemolysis, leading to concerns about drug toxicity. Postartemisinin delayed hemolysis (PADH) can occur 1-3 weeks after initiation...

2017
Jia Liu Xuezhi Hong Dong Lin Xiaohong Luo Mengya Zhu Hanyou Mo

CD4+ regulatory T (Treg) cells and T-helper 17 (Th17) cells have been shown to have important roles in rheumatoid arthritis (RA). In our previous study, it was demonstrated that artesunate was able to alter the Treg/Th17 ratio in patients with RA; however, the underlying mechanisms remain unclear. The present study established a male Sprague Dawley (SD) rat model of type II collagen-induced art...

2016
Issaka Sagara Abdoul Habib Beavogui Issaka Zongo Issiaka Soulama Isabelle Borghini-Fuhrer Bakary Fofana Daouda Camara Anyirékun F Somé Aboubacar S Coulibaly Oumar B Traore Niawanlou Dara Moïse J T Kabore Ismaila Thera Yves D Compaore Malick Minkael Sylla Frederic Nikiema Mamadou Saliou Diallo Alassane Dicko Jose Pedro Gil Steffen Borrmann Stephan Duparc Robert M Miller Ogobara K Doumbo Jangsik Shin Anders Bjorkman Jean-Bosco Ouedraogo Sodiomon B Sirima Abdoulaye A Djimdé

BACKGROUND Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first episode of malaria versus re-treatment in a substudy analysis. METHODS This planned substudy analysis of the randomised, open-label West African Network for Clinical Tria...

Journal: :PLoS ONE 2008
Daniel G. Wootton Hyginus Opara Giancarlo A. Biagini Maxwell K. Kanjala Stephan Duparc Paula L. Kirby Mary Woessner Colin Neate Maggie Nyirenda Hannah Blencowe Queen Dube-Mbeye Thomas Kanyok Stephen Ward Malcolm Molyneux Sam Dunyo Peter A. Winstanley

UNLABELLED The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil-dapsone (CPG-DDS) for the treatment of uncomplicated falciparum malaria. METHODS Open-label clinical trial comparing CPG-DDS alone or with artesunate 4, 2, or 1 mg/kg at medical centers in Blantyre, Malawi and Farafenni, The Gambia. The tri...

Journal: :Antimicrobial agents and chemotherapy 2010
Pharath Lim Chansuda Wongsrichanalai Pheaktra Chim Nimol Khim Saorin Kim Sophy Chy Rithy Sem Sina Nhem Poravuth Yi Socheat Duong Denis Mey Bouth Blaise Genton Hans-Peter Beck Jean Gerard Gobert William O Rogers Jean-Yves Coppee Thierry Fandeur Odile Mercereau-Puijalon Pascal Ringwald Jacques Le Bras Frederic Ariey

This study describes the results of in vitro antimalarial susceptibility assays and molecular polymorphisms of Plasmodium falciparum isolates from Cambodia. The samples were collected from patients enrolled in therapeutic efficacy studies (TES) conducted by the Cambodian National Malaria Control Program for the routine efficacy monitoring of artemisinin-based combination therapy (ACT) (artesuna...

Journal: :The American journal of tropical medicine and hygiene 2008
Issaka Sagara Abdoulbaki Diallo Mamady Kone Modibo Coulibaly Sory Ibrahima Diawara Ousmane Guindo Hamma Maiga Mohamed Balla Niambele Mady Sissoko Alassane Dicko Abdoulaye Djimde Ogobara K Doumbo

The choice of appropriate artemisin-based combination therapy depends on several factors (cost, efficacy, safety, reinfection rate, and simplicity of administration). In this study, we tested the hypothesis that artesunate-mefloquine (Artequin) is as efficacious as artemether-lumefantrine (Coartem) in treatment of uncomplicated Plasmodium falciparum malaria. The study was carried out from Augus...

2011
Beatrice Bachmeier Iduna Fichtner Peter H. Killian Emanuel Kronski Ulrich Pfeffer Thomas Efferth

Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinically used as anti-malarial agent, has recently revealed remarkable anti-tumor activity offering a r...

2011
Peng Longxi Fang Buwu Wang Yuan Gao Sinan

BACKGROUND Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen. p53, the "guardian of the genome", is a transcription factor that can bind to promoter regions of hundreds of genes where it either activates or suppresses gene expression. Thereby, p53 serves as a tumor suppressor by inducing cell cycle ar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید